论文部分内容阅读
原发性肝癌是世界上最常见的恶性肿瘤之一。我国的肝癌发病率较高,占世界肝癌发生总数的43%,每年约13万患者死于此病,占全球肝癌死亡病例的40%。肝动脉插管栓塞化疗(TACE)是目前公认的肝癌介入治疗的主要方法,其通过栓塞肿瘤供血动脉使肿瘤缺血坏死,同时抗肿瘤药物在肿瘤局部缓慢释放起到化疗作用,在抑制肿瘤生长、提高患者生存
Primary liver cancer is one of the most common malignancies in the world. The incidence of liver cancer in our country is high, accounting for 43% of the total number of liver cancer in the world and about 130,000 patients die of this disease each year, accounting for 40% of the global liver cancer deaths. Transcatheter Arterial Chemoembolization (TACE) is now the main method of interventional therapy for hepatocellular carcinoma. It embolizes the feeding artery of tumor to cause tumor necrosis and necrosis. At the same time, antitumor drugs play a chemo-therapeutic role in the local slow release of tumor, , Improve patient survival